Case Report
Lambert-Eaton Myasthenic Syndrome Secondary to Nivolumab and Ipilimumab in a Patient with Small-Cell Lung Cancer
| Test | Result | Reference range |
| TSH | 19.7 μIU/ml | 0.340-4.820 | Serum T4 | 1.9 μg/dl | 4.7-1.33 | Free T4 | <0.20 ng/dl | 0.59-1.80 | Serum T3 | 45 ng/dl | 60-181 | Random Cortisol | <0.5 μg/dl | | ACTH | 100 pg/ml | 7.2-6.3 (6 AM collection) | Prolactin | 15.8 ng/ml | 2.1-17.7 | IGF-I | 148 ng/ml | 34-232 | Testosterone | 263 ng/dl | 87-780 | FSH | 9.2 mIU/ml | Males, 13-70 years (1.4-18.1) | LH | 3.5 mIU/ml | Males, 20-70 years (1.5-9.3) |
|
|